Solara Active Pharma Sciences Ltd. Statistics
Want to see IN:SOLARA full AI Analyst Report?
Solara Active Pharma Sciences Ltd. (SOLARA) Stock Statistics & Valuation Metrics
Total Valuation
Solara Active Pharma Sciences Ltd. has a market cap or net worth of INR 30.51B. The enterprise value is INR 40.08B.
- Market Cap
- INR 30.51B
- Enterprise Value
- INR 40.08B
Share Statistics
Solara Active Pharma Sciences Ltd. has 48,070,286 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 48,070,286
- Owned by Insiders
- ―
- Owned by Institutions
- 1.01%
Financial Efficiency
Solara Active Pharma Sciences Ltd.’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is 4.36%.
- Return on Equity (ROE)
- -0.01
- Return on Assets (ROA)
- -0.00
- Return on Invested Capital (ROIC)
- 4.36%
- Return on Capital Employed (ROCE)
- 0.06
- Revenue Per Employee
- 8.20M
- Profits Per Employee
- -44.40K
- Employee Count
- 1,669
- Asset Turnover
- 0.59
- Inventory Turnover
- 3.16
Valuation Ratios
The current PE Ratio of Solara Active Pharma Sciences Ltd. is 83.94. Solara Active Pharma Sciences Ltd.’s PEG ratio is -0.01.
- PE Ratio
- 83.94
- PS Ratio
- 2.03
- PB Ratio
- 2.17
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Solara Active Pharma Sciences Ltd. had revenue of 13.69B and earned -74.10M in profits. Earnings per share was -1.68.
- Revenue
- 13.69B
- Gross Profit
- 3.66B
- Operating Income
- 870.70M
- Pretax Income
- -74.10M
- Net Income
- -74.10M
- EBITDA
- 1.87B
- Earnings Per Share (EPS)
- -1.68
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Solara Active Pharma Sciences Ltd. pays an annual dividend of INR 3.00, resulting in a dividend yield of ―
- Dividend Per Share
- INR 3.00
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 1.19%
Stock Price Statistics
- Beta
- 0.70
- 52-Week Price Change
- 14.81%
- 50-Day Moving Average
- 678.96
- 200-Day Moving Average
- 558.49
- Relative Strength Index (RSI)
- 45.02
- Average Volume (3m)
- 27.30K
Important Dates
Solara Active Pharma Sciences Ltd. upcoming earnings date is Feb 11, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 16, 2026
- Next Earnings Date
- Feb 11, 2027
- Ex-Dividend Date
- Aug 18, 2021
Financial Position
Solara Active Pharma Sciences Ltd. as a current ratio of 0.96, with Debt / Equity ratio of 54.80%
- Current Ratio
- 0.96
- Quick Ratio
- 0.60
- Debt to Market Cap
- 0.36
- Net Debt to EBITDA
- 3.41
- Interest Coverage Ratio
- 0.92
Taxes
In the past 12 months, Solara Active Pharma Sciences Ltd. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Solara Active Pharma Sciences Ltd. EV to EBITDA ratio is 15.46, with an EV/FCF ratio of 0.00.
- EV to Sales
- 2.37
- EV to EBITDA
- 15.46
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Solara Active Pharma Sciences Ltd. has INR 709.10M in cash and marketable securities with INR 5.91B in debt, giving a net cash position of -INR 5.20B billion.
- Cash & Marketable Securities
- INR 709.10M
- Total Debt
- INR 5.91B
- Net Cash
- -INR 5.20B
- Net Cash Per Share
- -INR 108.26
- Tangible Book Value Per Share
- INR 220.07
Margins
Gross margin is 26.82%, with operating margin of 8.39%, and net profit margin of 2.41%.
- Gross Margin
- 26.82%
- Operating Margin
- 8.39%
- Pretax Margin
- 2.41%
- Net Profit Margin
- 2.41%
- EBITDA Margin
- 15.33%
- EBIT Margin
- 8.49%
Analyst Forecast
The average price target for Solara Active Pharma Sciences Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 27.30%
- EPS Growth Forecast
- 456.80%
Scores
- Smart Score
- ―
- AI Score
- 51
